id	sid	tid	token	lemma	pos
dpc-432	1	1	dermatology	dermatology	NOUN
dpc-432	1	2	:	:	PUNCT
dpc-432	1	3	practical	practical	ADJ
dpc-432	1	4	and	and	CCONJ
dpc-432	1	5	conceptual	conceptual	ADJ
dpc-432	1	6	letter	letter	NOUN
dpc-432	2	1	|	|	ADV
dpc-432	2	2	dermatol	dermatol	ADJ
dpc-432	2	3	pract	pract	NOUN
dpc-432	2	4	concept	concept	NOUN
dpc-432	2	5	2018;8(2):10	2018;8(2):10	NUM
dpc-432	2	6	123	123	NUM
dpc-432	2	7	dermatology	dermatology	NOUN
dpc-432	2	8	practical	practical	ADJ
dpc-432	2	9	&	&	CCONJ
dpc-432	2	10	conceptual	conceptual	ADJ
dpc-432	2	11	www.derm101.com	www.derm101.com	X
dpc-432	2	12	mycosis	mycosis	NOUN
dpc-432	2	13	fungoides	fungoide	NOUN
dpc-432	2	14	(	(	PUNCT
dpc-432	2	15	mf	mf	X
dpc-432	2	16	)	)	PUNCT
dpc-432	2	17	,	,	PUNCT
dpc-432	2	18	the	the	DET
dpc-432	2	19	most	most	ADV
dpc-432	2	20	frequent	frequent	ADJ
dpc-432	2	21	primary	primary	ADJ
dpc-432	2	22	cutaneous	cutaneous	ADJ
dpc-432	2	23	lymphoma	lymphoma	NOUN
dpc-432	2	24	,	,	PUNCT
dpc-432	2	25	belongs	belong	VERB
dpc-432	2	26	to	to	ADP
dpc-432	2	27	the	the	DET
dpc-432	2	28	group	group	NOUN
dpc-432	2	29	of	of	ADP
dpc-432	2	30	extranodal	extranodal	NOUN
dpc-432	2	31	nonhodgkin	nonhodgkin	NOUN
dpc-432	2	32	lymphomas	lymphoma	NOUN
dpc-432	2	33	with	with	ADP
dpc-432	2	34	a	a	DET
dpc-432	2	35	mean	mean	ADJ
dpc-432	2	36	age	age	NOUN
dpc-432	2	37	at	at	ADP
dpc-432	2	38	onset	onset	NOUN
dpc-432	2	39	of	of	ADP
dpc-432	2	40	>	>	SYM
dpc-432	2	41	40	40	NUM
dpc-432	2	42	 	 	SPACE
dpc-432	2	43	years	year	NOUN
dpc-432	3	1	[	[	X
dpc-432	3	2	1	1	NUM
dpc-432	3	3	]	]	PUNCT
dpc-432	3	4	.	.	PUNCT
dpc-432	4	1	the	the	DET
dpc-432	4	2	manifestation	manifestation	NOUN
dpc-432	4	3	of	of	ADP
dpc-432	4	4	mf	mf	NOUN
dpc-432	4	5	in	in	ADP
dpc-432	4	6	children	child	NOUN
dpc-432	4	7	is	be	AUX
dpc-432	4	8	rare	rare	ADJ
dpc-432	4	9	and	and	CCONJ
dpc-432	4	10	has	have	AUX
dpc-432	4	11	only	only	ADV
dpc-432	4	12	been	be	AUX
dpc-432	4	13	studied	study	VERB
dpc-432	4	14	by	by	ADP
dpc-432	4	15	a	a	DET
dpc-432	4	16	number	number	NOUN
dpc-432	4	17	of	of	ADP
dpc-432	4	18	case	case	NOUN
dpc-432	4	19	series	series	NOUN
dpc-432	4	20	[	[	X
dpc-432	4	21	2	2	NUM
dpc-432	4	22	]	]	PUNCT
dpc-432	4	23	.	.	PUNCT
dpc-432	5	1	we	we	PRON
dpc-432	5	2	report	report	VERB
dpc-432	5	3	on	on	ADP
dpc-432	5	4	a	a	DET
dpc-432	5	5	 	 	SPACE
dpc-432	5	6	15	15	NUM
dpc-432	5	7	-	-	PUNCT
dpc-432	5	8	year	year	NOUN
dpc-432	5	9	-	-	PUNCT
dpc-432	5	10	old	old	ADJ
dpc-432	5	11	female	female	ADJ
dpc-432	5	12	adolescent	adolescent	ADJ
dpc-432	5	13	presenting	presenting	NOUN
dpc-432	5	14	with	with	ADP
dpc-432	5	15	pruritic	pruritic	ADJ
dpc-432	5	16	eczematous	eczematous	ADJ
dpc-432	5	17	lesions	lesion	NOUN
dpc-432	5	18	of	of	ADP
dpc-432	5	19	the	the	DET
dpc-432	5	20	neck	neck	NOUN
dpc-432	5	21	and	and	CCONJ
dpc-432	5	22	trunk	trunk	NOUN
dpc-432	5	23	that	that	PRON
dpc-432	5	24	had	have	AUX
dpc-432	5	25	persisted	persist	VERB
dpc-432	5	26	for	for	ADP
dpc-432	5	27	one	one	NUM
dpc-432	5	28	year	year	NOUN
dpc-432	5	29	(	(	PUNCT
dpc-432	5	30	figure	figure	NOUN
dpc-432	5	31	 	 	SPACE
dpc-432	5	32	1a	1a	NOUN
dpc-432	5	33	)	)	PUNCT
dpc-432	5	34	.	.	PUNCT
dpc-432	6	1	clinical	clinical	ADJ
dpc-432	6	2	examination	examination	NOUN
dpc-432	6	3	revealed	reveal	VERB
dpc-432	6	4	erythematous	erythematous	ADJ
dpc-432	6	5	,	,	PUNCT
dpc-432	6	6	oval	oval	NOUN
dpc-432	6	7	-	-	PUNCT
dpc-432	6	8	shaped	shape	VERB
dpc-432	6	9	to	to	ADP
dpc-432	6	10	polycyclic	polycyclic	NOUN
dpc-432	6	11	,	,	PUNCT
dpc-432	6	12	eczematous	eczematous	ADJ
dpc-432	6	13	macules	macule	NOUN
dpc-432	6	14	and	and	CCONJ
dpc-432	6	15	plaques	plaque	NOUN
dpc-432	6	16	with	with	ADP
dpc-432	6	17	a	a	DET
dpc-432	6	18	cigarette	cigarette	NOUN
dpc-432	6	19	paper	paper	NOUN
dpc-432	6	20	-	-	PUNCT
dpc-432	6	21	like	like	ADJ
dpc-432	6	22	cutaneous	cutaneous	ADJ
dpc-432	6	23	atrophy	atrophy	NOUN
dpc-432	6	24	and	and	CCONJ
dpc-432	6	25	moderate	moderate	ADJ
dpc-432	6	26	scaling	scaling	NOUN
dpc-432	6	27	(	(	PUNCT
dpc-432	6	28	figure	figure	NOUN
dpc-432	6	29	 	 	SPACE
dpc-432	6	30	1a	1a	PROPN
dpc-432	6	31	-	-	PUNCT
dpc-432	6	32	d	d	NOUN
dpc-432	6	33	)	)	PUNCT
dpc-432	6	34	.	.	PUNCT
dpc-432	7	1	the	the	DET
dpc-432	7	2	histopathological	histopathological	ADJ
dpc-432	7	3	as	as	ADV
dpc-432	7	4	well	well	ADV
dpc-432	7	5	as	as	ADP
dpc-432	7	6	immunohistochemical	immunohistochemical	ADJ
dpc-432	7	7	investigations	investigation	NOUN
dpc-432	7	8	included	include	VERB
dpc-432	7	9	stains	stain	NOUN
dpc-432	7	10	for	for	ADP
dpc-432	7	11	hematoxylin	hematoxylin	NOUN
dpc-432	7	12	-	-	PUNCT
dpc-432	7	13	eosin	eosin	NOUN
dpc-432	7	14	,	,	PUNCT
dpc-432	7	15	cd3	cd3	PROPN
dpc-432	7	16	,	,	PUNCT
dpc-432	7	17	cd4	cd4	PROPN
dpc-432	7	18	,	,	PUNCT
dpc-432	7	19	cd5	cd5	PROPN
dpc-432	7	20	,	,	PUNCT
dpc-432	7	21	cd8	cd8	PROPN
dpc-432	7	22	,	,	PUNCT
dpc-432	7	23	cd20	cd20	PROPN
dpc-432	7	24	,	,	PUNCT
dpc-432	7	25	and	and	CCONJ
dpc-432	7	26	cd30	cd30	PROPN
dpc-432	7	27	,	,	PUNCT
dpc-432	7	28	which	which	PRON
dpc-432	7	29	showed	show	VERB
dpc-432	7	30	a	a	DET
dpc-432	7	31	dense	dense	ADJ
dpc-432	7	32	infiltrate	infiltrate	NOUN
dpc-432	7	33	of	of	ADP
dpc-432	7	34	mainly	mainly	ADV
dpc-432	7	35	cd3	cd3	VERB
dpc-432	7	36	 	 	SPACE
dpc-432	7	37	and	and	CCONJ
dpc-432	7	38	cd4	cd4	PROPN
dpc-432	7	39	 	 	SPACE
dpc-432	7	40	positive	positive	ADJ
dpc-432	7	41	atypical	atypical	ADJ
dpc-432	7	42	lymphocytes	lymphocyte	NOUN
dpc-432	7	43	with	with	ADP
dpc-432	7	44	epidermal	epidermal	ADJ
dpc-432	7	45	exocytosis	exocytosis	NOUN
dpc-432	7	46	forming	form	VERB
dpc-432	7	47	pautrier	pautrier	NOUN
dpc-432	7	48	’s	’s	PART
dpc-432	7	49	microabscesses	microabscesse	NOUN
dpc-432	7	50	(	(	PUNCT
dpc-432	7	51	figure	figure	NOUN
dpc-432	7	52	 	 	SPACE
dpc-432	7	53	1e	1e	PROPN
dpc-432	7	54	-	-	PUNCT
dpc-432	7	55	g	g	NOUN
dpc-432	7	56	)	)	PUNCT
dpc-432	7	57	.	.	PUNCT
dpc-432	8	1	expression	expression	NOUN
dpc-432	8	2	of	of	ADP
dpc-432	8	3	cd5	cd5	PROPN
dpc-432	8	4	 	 	SPACE
dpc-432	8	5	as	as	ADP
dpc-432	8	6	a	a	DET
dpc-432	8	7	marker	marker	NOUN
dpc-432	8	8	of	of	ADP
dpc-432	8	9	potential	potential	ADJ
dpc-432	8	10	loss	loss	NOUN
dpc-432	8	11	of	of	ADP
dpc-432	8	12	differentiation	differentiation	NOUN
dpc-432	8	13	was	be	AUX
dpc-432	8	14	retained	retain	VERB
dpc-432	8	15	.	.	PUNCT
dpc-432	9	1	expectedly	expectedly	ADV
dpc-432	9	2	,	,	PUNCT
dpc-432	9	3	flow	flow	VERB
dpc-432	9	4	cytometry	cytometry	ADJ
dpc-432	9	5	analysis	analysis	NOUN
dpc-432	9	6	of	of	ADP
dpc-432	9	7	peripheral	peripheral	ADJ
dpc-432	9	8	blood	blood	NOUN
dpc-432	9	9	cells	cell	NOUN
dpc-432	9	10	showed	show	VERB
dpc-432	9	11	results	result	NOUN
dpc-432	9	12	within	within	ADP
dpc-432	9	13	normal	normal	ADJ
dpc-432	9	14	limits	limit	NOUN
dpc-432	9	15	(	(	PUNCT
dpc-432	9	16	36	36	NUM
dpc-432	9	17	%	%	NOUN
dpc-432	9	18	cd3	cd3	VERB
dpc-432	9	19	-	-	ADJ
dpc-432	9	20	positive	positive	ADJ
dpc-432	9	21	lymphocytes	lymphocyte	NOUN
dpc-432	9	22	,	,	PUNCT
dpc-432	9	23	cd4	cd4	PROPN
dpc-432	9	24	:	:	PUNCT
dpc-432	9	25	cd8	cd8	PROPN
dpc-432	9	26	 	 	SPACE
dpc-432	9	27	ratio	ratio	NOUN
dpc-432	9	28	of	of	ADP
dpc-432	9	29	 	 	SPACE
dpc-432	9	30	1.5	1.5	NUM
dpc-432	9	31	)	)	PUNCT
dpc-432	9	32	.	.	PUNCT
dpc-432	10	1	at	at	ADP
dpc-432	10	2	the	the	DET
dpc-432	10	3	molecular	molecular	ADJ
dpc-432	10	4	level	level	NOUN
dpc-432	10	5	,	,	PUNCT
dpc-432	10	6	a	a	DET
dpc-432	10	7	t	t	NOUN
dpc-432	10	8	-	-	PUNCT
dpc-432	10	9	cell	cell	NOUN
dpc-432	10	10	-	-	PUNCT
dpc-432	10	11	receptor	receptor	NOUN
dpc-432	10	12	(	(	PUNCT
dpc-432	10	13	tcr	tcr	PROPN
dpc-432	10	14	)	)	PUNCT
dpc-432	10	15	gene	gene	NOUN
dpc-432	10	16	rearrangement	rearrangement	NOUN
dpc-432	10	17	analysis	analysis	NOUN
dpc-432	10	18	from	from	ADP
dpc-432	10	19	lesional	lesional	ADJ
dpc-432	10	20	skin	skin	NOUN
dpc-432	10	21	showed	show	VERB
dpc-432	10	22	two	two	NUM
dpc-432	10	23	monoclonal	monoclonal	NOUN
dpc-432	10	24	gene	gene	NOUN
dpc-432	10	25	rearrangements	rearrangement	NOUN
dpc-432	10	26	,	,	PUNCT
dpc-432	10	27	agreeing	agree	VERB
dpc-432	10	28	well	well	ADV
dpc-432	10	29	with	with	ADP
dpc-432	10	30	the	the	DET
dpc-432	10	31	clinical	clinical	ADJ
dpc-432	10	32	and	and	CCONJ
dpc-432	10	33	histopathological	histopathological	ADJ
dpc-432	10	34	diagnosis	diagnosis	NOUN
dpc-432	10	35	of	of	ADP
dpc-432	10	36	stage	stage	NOUN
dpc-432	10	37	ia	ia	PROPN
dpc-432	10	38	mf	mf	VERB
dpc-432	10	39	.	.	PUNCT
dpc-432	11	1	a	a	DET
dpc-432	11	2	topical	topical	ADJ
dpc-432	11	3	treatment	treatment	NOUN
dpc-432	11	4	with	with	ADP
dpc-432	11	5	 	 	SPACE
dpc-432	11	6	0.1	0.1	NUM
dpc-432	11	7	%	%	NOUN
dpc-432	11	8	mometasone	mometasone	NOUN
dpc-432	11	9	furoate	furoate	NOUN
dpc-432	11	10	cream	cream	NOUN
dpc-432	11	11	was	be	AUX
dpc-432	11	12	initiated	initiate	VERB
dpc-432	11	13	and	and	CCONJ
dpc-432	11	14	achieved	achieve	VERB
dpc-432	11	15	a	a	DET
dpc-432	11	16	partial	partial	ADJ
dpc-432	11	17	response	response	NOUN
dpc-432	11	18	at	at	ADP
dpc-432	11	19	the	the	DET
dpc-432	11	20	time	time	NOUN
dpc-432	11	21	of	of	ADP
dpc-432	11	22	the	the	DET
dpc-432	11	23	first	first	ADJ
dpc-432	11	24	follow	follow	NOUN
dpc-432	11	25	-	-	PUNCT
dpc-432	11	26	up	up	ADP
dpc-432	11	27	examination	examination	NOUN
dpc-432	11	28	(	(	PUNCT
dpc-432	11	29	6	6	NUM
dpc-432	11	30	-	-	PUNCT
dpc-432	11	31	week	week	NOUN
dpc-432	11	32	 	 	SPACE
dpc-432	11	33	interval	interval	NOUN
dpc-432	11	34	)	)	PUNCT
dpc-432	11	35	.	.	PUNCT
dpc-432	12	1	mf	mf	NOUN
dpc-432	12	2	is	be	AUX
dpc-432	12	3	the	the	DET
dpc-432	12	4	most	most	ADV
dpc-432	12	5	common	common	ADJ
dpc-432	12	6	primary	primary	ADJ
dpc-432	12	7	cutaneous	cutaneous	ADJ
dpc-432	12	8	t	t	PROPN
dpc-432	12	9	-	-	PUNCT
dpc-432	12	10	cell	cell	NOUN
dpc-432	12	11	lymphoma	lymphoma	NOUN
dpc-432	12	12	.	.	PUNCT
dpc-432	13	1	however	however	ADV
dpc-432	13	2	,	,	PUNCT
dpc-432	13	3	in	in	ADP
dpc-432	13	4	children	child	NOUN
dpc-432	13	5	and	and	CCONJ
dpc-432	13	6	adolescents	adolescent	NOUN
dpc-432	13	7	mf	mf	X
dpc-432	13	8	is	be	AUX
dpc-432	13	9	very	very	ADV
dpc-432	13	10	rare	rare	ADJ
dpc-432	13	11	with	with	ADP
dpc-432	13	12	an	an	DET
dpc-432	13	13	incidence	incidence	NOUN
dpc-432	13	14	of	of	ADP
dpc-432	13	15	 	 	SPACE
dpc-432	13	16	0.05	0.05	NUM
dpc-432	13	17	 	 	SPACE
dpc-432	13	18	new	new	ADJ
dpc-432	13	19	cases	case	NOUN
dpc-432	13	20	per	per	ADP
dpc-432	13	21	year	year	NOUN
dpc-432	13	22	per	per	ADP
dpc-432	13	23	 	 	SPACE
dpc-432	13	24	100,000	100,000	NUM
dpc-432	13	25	[	[	X
dpc-432	13	26	3	3	NUM
dpc-432	13	27	]	]	PUNCT
dpc-432	13	28	.	.	PUNCT
dpc-432	14	1	while	while	SCONJ
dpc-432	14	2	in	in	ADP
dpc-432	14	3	adults	adult	NOUN
dpc-432	14	4	the	the	DET
dpc-432	14	5	female	female	NOUN
dpc-432	14	6	to	to	PART
dpc-432	14	7	male	male	ADJ
dpc-432	14	8	ratio	ratio	NOUN
dpc-432	14	9	was	be	AUX
dpc-432	14	10	reported	report	VERB
dpc-432	14	11	to	to	PART
dpc-432	14	12	be	be	AUX
dpc-432	14	13	 	 	SPACE
dpc-432	14	14	1:2	1:2	NUM
dpc-432	14	15	,	,	PUNCT
dpc-432	14	16	nanda	nanda	PROPN
dpc-432	14	17	et	et	NOUN
dpc-432	14	18	 	 	SPACE
dpc-432	14	19	al	al	PROPN
dpc-432	14	20	described	describe	VERB
dpc-432	14	21	a	a	DET
dpc-432	14	22	 	 	SPACE
dpc-432	14	23	1:1	1:1	NUM
dpc-432	14	24	 	 	SPACE
dpc-432	14	25	ratio	ratio	NOUN
dpc-432	14	26	in	in	ADP
dpc-432	14	27	children	child	NOUN
dpc-432	14	28	and	and	CCONJ
dpc-432	14	29	adolescents	adolescent	NOUN
dpc-432	15	1	[	[	X
dpc-432	15	2	4	4	NUM
dpc-432	15	3	]	]	PUNCT
dpc-432	15	4	.	.	PUNCT
dpc-432	16	1	the	the	DET
dpc-432	16	2	difficulties	difficulty	NOUN
dpc-432	16	3	in	in	ADP
dpc-432	16	4	diagnosing	diagnose	VERB
dpc-432	16	5	early	early	ADJ
dpc-432	16	6	stage	stage	NOUN
dpc-432	16	7	mf	mf	PUNCT
dpc-432	16	8	in	in	ADP
dpc-432	16	9	children	child	NOUN
dpc-432	16	10	arise	arise	VERB
dpc-432	16	11	from	from	ADP
dpc-432	16	12	the	the	DET
dpc-432	16	13	multitude	multitude	NOUN
dpc-432	16	14	of	of	ADP
dpc-432	16	15	differential	differential	ADJ
dpc-432	16	16	diagnoses	diagnosis	NOUN
dpc-432	16	17	with	with	ADP
dpc-432	16	18	similar	similar	ADJ
dpc-432	16	19	clinical	clinical	ADJ
dpc-432	16	20	morphology	morphology	NOUN
dpc-432	16	21	but	but	CCONJ
dpc-432	16	22	much	much	ADV
dpc-432	16	23	higher	high	ADJ
dpc-432	16	24	incidences	incidence	NOUN
dpc-432	16	25	in	in	ADP
dpc-432	16	26	this	this	DET
dpc-432	16	27	specific	specific	ADJ
dpc-432	16	28	age	age	NOUN
dpc-432	16	29	group	group	NOUN
dpc-432	16	30	.	.	PUNCT
dpc-432	17	1	in	in	ADP
dpc-432	17	2	mf	mf	NOUN
dpc-432	17	3	three	three	NUM
dpc-432	17	4	stages	stage	NOUN
dpc-432	17	5	may	may	AUX
dpc-432	17	6	be	be	AUX
dpc-432	17	7	differentiated	differentiate	VERB
dpc-432	17	8	clinically	clinically	ADV
dpc-432	17	9	.	.	PUNCT
dpc-432	18	1	the	the	DET
dpc-432	18	2	patch	patch	ADJ
dpc-432	18	3	stage	stage	NOUN
dpc-432	18	4	presents	present	VERB
dpc-432	18	5	with	with	ADP
dpc-432	18	6	eczematous	eczematous	ADJ
dpc-432	18	7	skin	skin	NOUN
dpc-432	18	8	lesions	lesion	NOUN
dpc-432	18	9	,	,	PUNCT
dpc-432	18	10	moderate	moderate	ADJ
dpc-432	18	11	desquamation	desquamation	NOUN
dpc-432	18	12	,	,	PUNCT
dpc-432	18	13	cutaneous	cutaneous	ADJ
dpc-432	18	14	atrophy	atrophy	NOUN
dpc-432	18	15	,	,	PUNCT
dpc-432	18	16	and	and	CCONJ
dpc-432	18	17	predilection	predilection	NOUN
dpc-432	18	18	for	for	ADP
dpc-432	18	19	non	non	ADJ
dpc-432	18	20	-	-	ADJ
dpc-432	18	21	sun	sun	ADJ
dpc-432	18	22	-	-	PUNCT
dpc-432	18	23	exposed	expose	VERB
dpc-432	18	24	skin	skin	NOUN
dpc-432	18	25	areas	area	NOUN
dpc-432	18	26	[	[	X
dpc-432	18	27	5	5	NUM
dpc-432	18	28	]	]	PUNCT
dpc-432	18	29	.	.	PUNCT
dpc-432	19	1	in	in	ADP
dpc-432	19	2	children	child	NOUN
dpc-432	19	3	such	such	ADJ
dpc-432	19	4	lesions	lesion	NOUN
dpc-432	19	5	are	be	AUX
dpc-432	19	6	often	often	ADV
dpc-432	19	7	erroneously	erroneously	ADV
dpc-432	19	8	diagnosed	diagnose	VERB
dpc-432	19	9	as	as	ADP
dpc-432	19	10	(	(	PUNCT
dpc-432	19	11	atopic	atopic	NOUN
dpc-432	19	12	)	)	PUNCT
dpc-432	19	13	eczema	eczema	NOUN
dpc-432	19	14	,	,	PUNCT
dpc-432	19	15	dermatophyte	dermatophyte	VERB
dpc-432	19	16	infection	infection	NOUN
dpc-432	19	17	,	,	PUNCT
dpc-432	19	18	or	or	CCONJ
dpc-432	19	19	early	early	ADJ
dpc-432	19	20	onset	onset	VERB
dpc-432	19	21	psoriasis	psoriasis	NOUN
dpc-432	19	22	vulgaris	vulgaris	NOUN
dpc-432	19	23	[	[	X
dpc-432	19	24	2	2	NUM
dpc-432	19	25	]	]	PUNCT
dpc-432	19	26	.	.	PUNCT
dpc-432	20	1	therefore	therefore	ADV
dpc-432	20	2	,	,	PUNCT
dpc-432	20	3	diagnosis	diagnosis	NOUN
dpc-432	20	4	is	be	AUX
dpc-432	20	5	often	often	ADV
dpc-432	20	6	delayed	delay	VERB
dpc-432	20	7	until	until	SCONJ
dpc-432	20	8	the	the	DET
dpc-432	20	9	patches	patch	NOUN
dpc-432	20	10	evolve	evolve	VERB
dpc-432	20	11	into	into	ADP
dpc-432	20	12	infiltrative	infiltrative	ADJ
dpc-432	20	13	plaques	plaque	NOUN
dpc-432	20	14	(	(	PUNCT
dpc-432	20	15	plaque	plaque	NOUN
dpc-432	20	16	stage	stage	NOUN
dpc-432	20	17	)	)	PUNCT
dpc-432	20	18	or	or	CCONJ
dpc-432	20	19	tumors	tumor	NOUN
dpc-432	20	20	(	(	PUNCT
dpc-432	20	21	tumor	tumor	NOUN
dpc-432	20	22	stage	stage	NOUN
dpc-432	20	23	)	)	PUNCT
dpc-432	20	24	,	,	PUNCT
dpc-432	20	25	with	with	ADP
dpc-432	20	26	all	all	DET
dpc-432	20	27	three	three	NUM
dpc-432	20	28	types	type	NOUN
dpc-432	20	29	of	of	ADP
dpc-432	20	30	skin	skin	NOUN
dpc-432	20	31	patholomycosis	patholomycosis	NOUN
dpc-432	20	32	fungoides	fungoide	NOUN
dpc-432	20	33	in	in	ADP
dpc-432	20	34	a	a	DET
dpc-432	20	35	 	 	SPACE
dpc-432	20	36	15	15	NUM
dpc-432	20	37	-	-	PUNCT
dpc-432	20	38	year	year	NOUN
dpc-432	20	39	-	-	PUNCT
dpc-432	20	40	old	old	ADJ
dpc-432	20	41	adolescent	adolescent	ADJ
dpc-432	20	42	sarah	sarah	PROPN
dpc-432	20	43	estelmann1	estelmann1	PROPN
dpc-432	20	44	,	,	PUNCT
dpc-432	20	45	anna	anna	PROPN
dpc-432	20	46	neuberger1	neuberger1	PROPN
dpc-432	20	47	,	,	PUNCT
dpc-432	20	48	ferdinand	ferdinand	PROPN
dpc-432	20	49	toberer1	toberer1	PROPN
dpc-432	20	50	,	,	PUNCT
dpc-432	20	51	christine	christine	PROPN
dpc-432	20	52	fink1	fink1	PROPN
dpc-432	20	53	,	,	PUNCT
dpc-432	20	54	alexander	alexander	PROPN
dpc-432	20	55	enk1	enk1	PROPN
dpc-432	20	56	,	,	PUNCT
dpc-432	20	57	holger	holger	PROPN
dpc-432	20	58	a.	a.	PROPN
dpc-432	20	59	haenssle1	haenssle1	PROPN
dpc-432	20	60	1	1	NUM
dpc-432	20	61	 	 	SPACE
dpc-432	20	62	department	department	NOUN
dpc-432	20	63	of	of	ADP
dpc-432	20	64	dermatology	dermatology	NOUN
dpc-432	20	65	,	,	PUNCT
dpc-432	20	66	venereology	venereology	NOUN
dpc-432	20	67	,	,	PUNCT
dpc-432	20	68	and	and	CCONJ
dpc-432	20	69	allergology	allergology	NOUN
dpc-432	20	70	;	;	PUNCT
dpc-432	20	71	university	university	NOUN
dpc-432	20	72	medical	medical	ADJ
dpc-432	20	73	center	center	NOUN
dpc-432	20	74	,	,	PUNCT
dpc-432	20	75	ruprecht	ruprecht	NOUN
dpc-432	20	76	-	-	PUNCT
dpc-432	20	77	karls	karl	NOUN
dpc-432	20	78	university	university	PROPN
dpc-432	20	79	,	,	PUNCT
dpc-432	20	80	heidelberg	heidelberg	PROPN
dpc-432	20	81	,	,	PUNCT
dpc-432	20	82	germany	germany	PROPN
dpc-432	20	83	key	key	ADJ
dpc-432	20	84	words	word	NOUN
dpc-432	20	85	:	:	PUNCT
dpc-432	20	86	mycosis	mycosis	NOUN
dpc-432	20	87	fungoides	fungoide	NOUN
dpc-432	20	88	,	,	PUNCT
dpc-432	20	89	childhood	childhood	NOUN
dpc-432	20	90	,	,	PUNCT
dpc-432	20	91	adolescent	adolescent	ADJ
dpc-432	20	92	citation	citation	NOUN
dpc-432	20	93	:	:	PUNCT
dpc-432	20	94	estelmann	estelmann	PROPN
dpc-432	20	95	s	s	PROPN
dpc-432	20	96	,	,	PUNCT
dpc-432	20	97	neuberger	neuberger	PROPN
dpc-432	20	98	a	a	NOUN
dpc-432	20	99	,	,	PUNCT
dpc-432	20	100	toberer	toberer	NOUN
dpc-432	20	101	f	f	PROPN
dpc-432	20	102	,	,	PUNCT
dpc-432	20	103	fink	fink	PROPN
dpc-432	20	104	c	c	PROPN
dpc-432	20	105	,	,	PUNCT
dpc-432	20	106	enk	enk	PROPN
dpc-432	20	107	a	a	PRON
dpc-432	20	108	,	,	PUNCT
dpc-432	20	109	haenssle	haenssle	PROPN
dpc-432	20	110	ha	ha	INTJ
dpc-432	20	111	.	.	PROPN
dpc-432	20	112	mycosis	mycosis	NOUN
dpc-432	20	113	fungoides	fungoide	NOUN
dpc-432	20	114	in	in	ADP
dpc-432	20	115	a	a	DET
dpc-432	20	116	 	 	SPACE
dpc-432	20	117	15	15	NUM
dpc-432	20	118	-	-	PUNCT
dpc-432	20	119	year	year	NOUN
dpc-432	20	120	-	-	PUNCT
dpc-432	20	121	old	old	ADJ
dpc-432	20	122	adolescent	adolescent	ADJ
dpc-432	20	123	.	.	PUNCT
dpc-432	21	1	dermatol	dermatol	NOUN
dpc-432	21	2	pract	pract	PROPN
dpc-432	21	3	concept	concept	NOUN
dpc-432	21	4	.	.	PUNCT
dpc-432	22	1	2018;8(2):123	2018;8(2):123	NUM
dpc-432	22	2	-	-	SYM
dpc-432	22	3	125	125	NUM
dpc-432	22	4	.	.	PUNCT
dpc-432	23	1	doi	doi	NOUN
dpc-432	23	2	:	:	PUNCT
dpc-432	23	3	https://doi.org/10.5826/dpc.0802a10	https://doi.org/10.5826/dpc.0802a10	PROPN
dpc-432	23	4	received	receive	VERB
dpc-432	23	5	:	:	PUNCT
dpc-432	23	6	november	november	PROPN
dpc-432	23	7	 	 	SPACE
dpc-432	23	8	12	12	NUM
dpc-432	23	9	,	,	PUNCT
dpc-432	23	10	2017	2017	NUM
dpc-432	23	11	;	;	PUNCT
dpc-432	23	12	accepted	accept	VERB
dpc-432	23	13	:	:	PUNCT
dpc-432	23	14	december	december	PROPN
dpc-432	23	15	 	 	SPACE
dpc-432	23	16	12	12	NUM
dpc-432	23	17	,	,	PUNCT
dpc-432	23	18	2017	2017	NUM
dpc-432	23	19	;	;	PUNCT
dpc-432	23	20	published	publish	VERB
dpc-432	23	21	:	:	PUNCT
dpc-432	23	22	april	april	PROPN
dpc-432	23	23	 	 	SPACE
dpc-432	23	24	30	30	NUM
dpc-432	23	25	,	,	PUNCT
dpc-432	23	26	2018	2018	NUM
dpc-432	23	27	copyright	copyright	NOUN
dpc-432	23	28	:	:	PUNCT
dpc-432	24	1	©	©	PROPN
dpc-432	24	2	2018	2018	NUM
dpc-432	24	3	 	 	SPACE
dpc-432	24	4	estelmann	estelmann	PROPN
dpc-432	24	5	et	et	PROPN
dpc-432	24	6	 	 	SPACE
dpc-432	24	7	al	al	PROPN
dpc-432	24	8	.	.	PUNCT
dpc-432	25	1	this	this	PRON
dpc-432	25	2	is	be	AUX
dpc-432	25	3	an	an	DET
dpc-432	25	4	open	open	ADJ
dpc-432	25	5	-	-	PUNCT
dpc-432	25	6	access	access	NOUN
dpc-432	25	7	article	article	NOUN
dpc-432	25	8	distributed	distribute	VERB
dpc-432	25	9	under	under	ADP
dpc-432	25	10	the	the	DET
dpc-432	25	11	terms	term	NOUN
dpc-432	25	12	of	of	ADP
dpc-432	25	13	the	the	DET
dpc-432	25	14	creative	creative	ADJ
dpc-432	25	15	commons	common	NOUN
dpc-432	25	16	attribution	attribution	NOUN
dpc-432	25	17	license	license	NOUN
dpc-432	25	18	,	,	PUNCT
dpc-432	25	19	which	which	PRON
dpc-432	25	20	permits	permit	VERB
dpc-432	25	21	unrestricted	unrestricted	ADJ
dpc-432	25	22	use	use	NOUN
dpc-432	25	23	,	,	PUNCT
dpc-432	25	24	distribution	distribution	NOUN
dpc-432	25	25	,	,	PUNCT
dpc-432	25	26	and	and	CCONJ
dpc-432	25	27	reproduction	reproduction	NOUN
dpc-432	25	28	in	in	ADP
dpc-432	25	29	any	any	DET
dpc-432	25	30	medium	medium	NOUN
dpc-432	25	31	,	,	PUNCT
dpc-432	25	32	provided	provide	VERB
dpc-432	25	33	the	the	DET
dpc-432	25	34	original	original	ADJ
dpc-432	25	35	author	author	NOUN
dpc-432	25	36	and	and	CCONJ
dpc-432	25	37	source	source	NOUN
dpc-432	25	38	are	be	AUX
dpc-432	25	39	 	 	SPACE
dpc-432	25	40	credited	credit	VERB
dpc-432	25	41	.	.	PUNCT
dpc-432	26	1	funding	funding	NOUN
dpc-432	26	2	:	:	PUNCT
dpc-432	26	3	none	none	NOUN
dpc-432	26	4	.	.	PUNCT
dpc-432	27	1	competing	compete	VERB
dpc-432	27	2	interests	interest	NOUN
dpc-432	27	3	:	:	PUNCT
dpc-432	27	4	the	the	DET
dpc-432	27	5	authors	author	NOUN
dpc-432	27	6	have	have	VERB
dpc-432	27	7	no	no	DET
dpc-432	27	8	conflicts	conflict	NOUN
dpc-432	27	9	of	of	ADP
dpc-432	27	10	interest	interest	NOUN
dpc-432	27	11	to	to	PART
dpc-432	27	12	 	 	SPACE
dpc-432	27	13	disclose	disclose	VERB
dpc-432	27	14	.	.	PUNCT
dpc-432	28	1	all	all	DET
dpc-432	28	2	authors	author	NOUN
dpc-432	28	3	have	have	AUX
dpc-432	28	4	contributed	contribute	VERB
dpc-432	28	5	significantly	significantly	ADV
dpc-432	28	6	to	to	ADP
dpc-432	28	7	this	this	DET
dpc-432	28	8	publication	publication	NOUN
dpc-432	28	9	.	.	PUNCT
dpc-432	29	1	corresponding	correspond	VERB
dpc-432	29	2	author	author	NOUN
dpc-432	29	3	:	:	PUNCT
dpc-432	29	4	holger	holger	NOUN
dpc-432	29	5	a.	a.	NOUN
dpc-432	29	6	haenssle	haenssle	PROPN
dpc-432	29	7	,	,	PUNCT
dpc-432	29	8	md	md	PROPN
dpc-432	29	9	,	,	PUNCT
dpc-432	29	10	department	department	PROPN
dpc-432	29	11	of	of	ADP
dpc-432	29	12	dermatology	dermatology	NOUN
dpc-432	29	13	,	,	PUNCT
dpc-432	29	14	venereology	venereology	NOUN
dpc-432	29	15	and	and	CCONJ
dpc-432	29	16	allergology	allergology	NOUN
dpc-432	29	17	,	,	PUNCT
dpc-432	29	18	university	university	NOUN
dpc-432	29	19	medical	medical	ADJ
dpc-432	29	20	center	center	NOUN
dpc-432	29	21	,	,	PUNCT
dpc-432	29	22	ruprecht	ruprecht	NOUN
dpc-432	29	23	-	-	PUNCT
dpc-432	29	24	karls	karl	NOUN
dpc-432	29	25	university	university	NOUN
dpc-432	29	26	,	,	PUNCT
dpc-432	29	27	i	i	PRON
dpc-432	29	28	m	m	PROPN
dpc-432	29	29	neuenheimer	neuenheimer	ADJ
dpc-432	29	30	feld	feld	PROPN
dpc-432	29	31	 	 	SPACE
dpc-432	29	32	440	440	NUM
dpc-432	29	33	,	,	PUNCT
dpc-432	29	34	69120	69120	NUM
dpc-432	29	35	 	 	SPACE
dpc-432	29	36	heidelberg	heidelberg	PROPN
dpc-432	29	37	,	,	PUNCT
dpc-432	29	38	germany	germany	PROPN
dpc-432	29	39	.	.	PUNCT
dpc-432	30	1	tel	tel	PROPN
dpc-432	30	2	.	.	PUNCT
dpc-432	31	1	+49	+49	NOUN
dpc-432	31	2	-	-	PUNCT
dpc-432	31	3	6221	6221	NUM
dpc-432	31	4	-	-	PUNCT
dpc-432	31	5	56	56	NUM
dpc-432	31	6	-	-	PUNCT
dpc-432	31	7	39555	39555	NUM
dpc-432	31	8	;	;	PUNCT
dpc-432	32	1	fax	fax	NOUN
dpc-432	32	2	.	.	PROPN
dpc-432	33	1	+49	+49	NOUN
dpc-432	33	2	-	-	PUNCT
dpc-432	33	3	6221	6221	NUM
dpc-432	33	4	-	-	PUNCT
dpc-432	33	5	56	56	NUM
dpc-432	33	6	-	-	PUNCT
dpc-432	33	7	7771	7771	NUM
dpc-432	33	8	.	.	PUNCT
dpc-432	34	1	email	email	NOUN
dpc-432	34	2	:	:	PUNCT
dpc-432	34	3	holger.haenssle@med.uni-heidelberg.de	holger.haenssle@med.uni-heidelberg.de	PROPN
dpc-432	34	4	124	124	NUM
dpc-432	34	5	letter	letter	NOUN
dpc-432	35	1	|	|	INTJ
dpc-432	35	2	dermatol	dermatol	ADJ
dpc-432	35	3	pract	pract	NOUN
dpc-432	35	4	concept	concept	NOUN
dpc-432	35	5	2018;8(2):10	2018;8(2):10	NUM
dpc-432	35	6	figure	figure	NOUN
dpc-432	35	7	1	1	NUM
dpc-432	35	8	.	.	PUNCT
dpc-432	35	9	clinical	clinical	ADJ
dpc-432	35	10	images	image	NOUN
dpc-432	35	11	and	and	CCONJ
dpc-432	35	12	histopathological	histopathological	ADJ
dpc-432	35	13	examination	examination	NOUN
dpc-432	35	14	of	of	ADP
dpc-432	35	15	patches	patch	NOUN
dpc-432	35	16	and	and	CCONJ
dpc-432	35	17	plaques	plaque	NOUN
dpc-432	35	18	in	in	ADP
dpc-432	35	19	a	a	DET
dpc-432	35	20	 	 	SPACE
dpc-432	35	21	15	15	NUM
dpc-432	35	22	-	-	PUNCT
dpc-432	35	23	year	year	NOUN
dpc-432	35	24	-	-	PUNCT
dpc-432	35	25	old	old	ADJ
dpc-432	35	26	girl	girl	NOUN
dpc-432	35	27	with	with	ADP
dpc-432	35	28	mycosis	mycosis	NOUN
dpc-432	35	29	fungoides	fungoide	NOUN
dpc-432	35	30	.	.	PUNCT
dpc-432	36	1	the	the	DET
dpc-432	36	2	overview	overview	NOUN
dpc-432	36	3	image	image	NOUN
dpc-432	36	4	shows	show	NOUN
dpc-432	36	5	disseminated	disseminate	VERB
dpc-432	36	6	,	,	PUNCT
dpc-432	36	7	bizarrely	bizarrely	ADV
dpc-432	36	8	shaped	shaped	ADJ
dpc-432	36	9	,	,	PUNCT
dpc-432	36	10	erythematous	erythematous	ADJ
dpc-432	36	11	lesions	lesion	NOUN
dpc-432	36	12	on	on	ADP
dpc-432	36	13	the	the	DET
dpc-432	36	14	back	back	NOUN
dpc-432	36	15	(	(	PUNCT
dpc-432	36	16	a	a	NOUN
dpc-432	36	17	)	)	PUNCT
dpc-432	36	18	.	.	PUNCT
dpc-432	37	1	close	close	ADJ
dpc-432	37	2	-	-	PUNCT
dpc-432	37	3	up	up	ADP
dpc-432	37	4	images	image	NOUN
dpc-432	37	5	reveal	reveal	VERB
dpc-432	37	6	more	more	ADV
dpc-432	37	7	infiltrated	infiltrate	VERB
dpc-432	37	8	erythematous	erythematous	ADJ
dpc-432	37	9	plaques	plaque	NOUN
dpc-432	37	10	with	with	ADP
dpc-432	37	11	scaling	scaling	NOUN
dpc-432	37	12	(	(	PUNCT
dpc-432	37	13	b	b	NOUN
dpc-432	37	14	)	)	PUNCT
dpc-432	37	15	and	and	CCONJ
dpc-432	37	16	patches	patch	NOUN
dpc-432	37	17	with	with	ADP
dpc-432	37	18	epidermal	epidermal	ADJ
dpc-432	37	19	atrophy	atrophy	NOUN
dpc-432	37	20	,	,	PUNCT
dpc-432	37	21	sharply	sharply	ADV
dpc-432	37	22	demarcated	demarcate	VERB
dpc-432	37	23	borders	border	NOUN
dpc-432	37	24	and	and	CCONJ
dpc-432	37	25	moderate	moderate	ADJ
dpc-432	37	26	scaling	scaling	NOUN
dpc-432	37	27	(	(	PUNCT
dpc-432	37	28	c	c	X
dpc-432	37	29	,	,	PUNCT
dpc-432	37	30	d	d	NOUN
dpc-432	37	31	)	)	PUNCT
dpc-432	37	32	.	.	PUNCT
dpc-432	38	1	hematoxylin	hematoxylin	PROPN
dpc-432	38	2	and	and	CCONJ
dpc-432	38	3	eosin	eosin	NOUN
dpc-432	38	4	staining	stain	VERB
dpc-432	38	5	(	(	PUNCT
dpc-432	38	6	e	e	NOUN
dpc-432	38	7	)	)	PUNCT
dpc-432	38	8	reveals	reveal	VERB
dpc-432	38	9	psoriasiform	psoriasiform	VERB
dpc-432	38	10	epidermal	epidermal	ADJ
dpc-432	38	11	hyperplasia	hyperplasia	NOUN
dpc-432	38	12	and	and	CCONJ
dpc-432	38	13	a	a	DET
dpc-432	38	14	superficial	superficial	ADJ
dpc-432	38	15	band	band	NOUN
dpc-432	38	16	-	-	PUNCT
dpc-432	38	17	like	like	ADJ
dpc-432	38	18	lymphocytic	lymphocytic	ADJ
dpc-432	38	19	infiltrate	infiltrate	NOUN
dpc-432	38	20	.	.	PUNCT
dpc-432	39	1	some	some	PRON
dpc-432	39	2	of	of	ADP
dpc-432	39	3	the	the	DET
dpc-432	39	4	atypical	atypical	ADJ
dpc-432	39	5	lymphocytes	lymphocyte	NOUN
dpc-432	39	6	are	be	AUX
dpc-432	39	7	present	present	ADJ
dpc-432	39	8	within	within	ADP
dpc-432	39	9	the	the	DET
dpc-432	39	10	epidermis	epidermis	NOUN
dpc-432	39	11	(	(	PUNCT
dpc-432	39	12	original	original	ADJ
dpc-432	39	13	magnification	magnification	NOUN
dpc-432	39	14	x	x	NOUN
dpc-432	39	15	 	 	SPACE
dpc-432	39	16	100	100	NUM
dpc-432	39	17	)	)	PUNCT
dpc-432	39	18	.	.	PUNCT
dpc-432	40	1	at	at	ADP
dpc-432	40	2	higher	high	ADJ
dpc-432	40	3	magnification	magnification	NOUN
dpc-432	40	4	typical	typical	ADJ
dpc-432	40	5	pautrier	pautrier	ADJ
dpc-432	40	6	microabscesses	microabscesse	NOUN
dpc-432	40	7	show	show	VERB
dpc-432	40	8	atypical	atypical	ADJ
dpc-432	40	9	lymphocytes	lymphocyte	NOUN
dpc-432	40	10	with	with	ADP
dpc-432	40	11	hyperchromatic	hyperchromatic	ADJ
dpc-432	40	12	and	and	CCONJ
dpc-432	40	13	irregular	irregular	ADJ
dpc-432	40	14	nuclei	nucleus	NOUN
dpc-432	40	15	(	(	PUNCT
dpc-432	40	16	f	f	X
dpc-432	40	17	,	,	PUNCT
dpc-432	40	18	original	original	ADJ
dpc-432	40	19	magnification	magnification	NOUN
dpc-432	40	20	x	x	NOUN
dpc-432	40	21	 	 	SPACE
dpc-432	40	22	630	630	NUM
dpc-432	40	23	)	)	PUNCT
dpc-432	40	24	.	.	PUNCT
dpc-432	41	1	immunostaining	immunostaine	VERB
dpc-432	41	2	shows	show	VERB
dpc-432	41	3	positivity	positivity	NOUN
dpc-432	41	4	for	for	ADP
dpc-432	41	5	cd3	cd3	PROPN
dpc-432	41	6	 	 	SPACE
dpc-432	41	7	marker	marker	NOUN
dpc-432	41	8	in	in	ADP
dpc-432	41	9	epidermotropic	epidermotropic	NOUN
dpc-432	41	10	,	,	PUNCT
dpc-432	41	11	intraepidermal	intraepidermal	ADJ
dpc-432	41	12	t	t	NOUN
dpc-432	41	13	lymphocytes	lymphocyte	NOUN
dpc-432	41	14	(	(	PUNCT
dpc-432	41	15	g	g	NOUN
dpc-432	41	16	,	,	PUNCT
dpc-432	41	17	original	original	ADJ
dpc-432	41	18	magnification	magnification	NOUN
dpc-432	41	19	x	x	NOUN
dpc-432	41	20	 	 	SPACE
dpc-432	41	21	200	200	NUM
dpc-432	41	22	)	)	PUNCT
dpc-432	41	23	.	.	PUNCT
dpc-432	42	1	[	[	X
dpc-432	42	2	copyright	copyright	NOUN
dpc-432	42	3	:	:	PUNCT
dpc-432	42	4	©	©	PROPN
dpc-432	42	5	2018	2018	NUM
dpc-432	42	6	 	 	SPACE
dpc-432	42	7	estelmann	estelmann	PROPN
dpc-432	42	8	et	et	PROPN
dpc-432	42	9	 	 	SPACE
dpc-432	42	10	al	al	PROPN
dpc-432	42	11	.	.	PROPN
dpc-432	42	12	]	]	PUNCT
dpc-432	42	13	letter	letter	NOUN
dpc-432	43	1	|	|	INTJ
dpc-432	43	2	dermatol	dermatol	ADJ
dpc-432	43	3	pract	pract	NOUN
dpc-432	43	4	concept	concept	NOUN
dpc-432	43	5	2018;8(2):10	2018;8(2):10	NUM
dpc-432	43	6	125	125	NUM
dpc-432	43	7	ally	ally	NOUN
dpc-432	43	8	add	add	VERB
dpc-432	43	9	up	up	ADP
dpc-432	43	10	to	to	ADP
dpc-432	43	11	a	a	DET
dpc-432	43	12	relevant	relevant	ADJ
dpc-432	43	13	increase	increase	NOUN
dpc-432	43	14	of	of	ADP
dpc-432	43	15	the	the	DET
dpc-432	43	16	risk	risk	NOUN
dpc-432	43	17	of	of	ADP
dpc-432	43	18	uv	uv	NOUN
dpc-432	43	19	-	-	PUNCT
dpc-432	43	20	induced	induce	VERB
dpc-432	43	21	skin	skin	NOUN
dpc-432	43	22	cancers	cancer	NOUN
dpc-432	43	23	[	[	X
dpc-432	43	24	3	3	NUM
dpc-432	43	25	]	]	PUNCT
dpc-432	43	26	.	.	PUNCT
dpc-432	44	1	references	reference	NOUN
dpc-432	44	2	1	1	NUM
dpc-432	44	3	.	.	PUNCT
dpc-432	45	1	trautinger	trautinger	PROPN
dpc-432	45	2	f	f	PROPN
dpc-432	45	3	,	,	PUNCT
dpc-432	45	4	eder	eder	NOUN
dpc-432	45	5	j	j	PROPN
dpc-432	45	6	,	,	PUNCT
dpc-432	45	7	assaf	assaf	PROPN
dpc-432	45	8	c	c	PROPN
dpc-432	45	9	,	,	PUNCT
dpc-432	45	10	et	et	PROPN
dpc-432	45	11	 	 	SPACE
dpc-432	45	12	al	al	PROPN
dpc-432	45	13	.	.	PUNCT
dpc-432	45	14	european	european	PROPN
dpc-432	45	15	organisation	organisation	PROPN
dpc-432	45	16	for	for	ADP
dpc-432	45	17	research	research	NOUN
dpc-432	45	18	and	and	CCONJ
dpc-432	45	19	treatment	treatment	NOUN
dpc-432	45	20	of	of	ADP
dpc-432	45	21	cancer	cancer	NOUN
dpc-432	45	22	consensus	consensus	NOUN
dpc-432	45	23	recommendations	recommendation	NOUN
dpc-432	45	24	for	for	ADP
dpc-432	45	25	the	the	DET
dpc-432	45	26	treatment	treatment	NOUN
dpc-432	45	27	of	of	ADP
dpc-432	45	28	mycosis	mycosis	NOUN
dpc-432	45	29	fungoides	fungoide	NOUN
dpc-432	45	30	/	/	SYM
dpc-432	45	31	sézary	sézary	ADJ
dpc-432	45	32	syndrome	syndrome	NOUN
dpc-432	45	33	—	—	PUNCT
dpc-432	45	34	update	update	NOUN
dpc-432	45	35	 	 	SPACE
dpc-432	45	36	2017	2017	NUM
dpc-432	45	37	.	.	PUNCT
dpc-432	46	1	eur	eur	PROPN
dpc-432	46	2	j	j	PROPN
dpc-432	46	3	cancer	cancer	NOUN
dpc-432	46	4	.	.	PUNCT
dpc-432	47	1	2017;77:57	2017;77:57	NUM
dpc-432	47	2	-	-	SYM
dpc-432	47	3	74	74	NUM
dpc-432	47	4	.	.	PUNCT
dpc-432	48	1	2	2	X
dpc-432	48	2	.	.	X
dpc-432	48	3	boulos	boulos	PROPN
dpc-432	48	4	s	s	PROPN
dpc-432	48	5	,	,	PUNCT
dpc-432	48	6	vaid	vaid	ADJ
dpc-432	48	7	r	r	NOUN
dpc-432	48	8	,	,	PUNCT
dpc-432	48	9	aladily	aladily	PROPN
dpc-432	48	10	tn	tn	PROPN
dpc-432	48	11	,	,	PUNCT
dpc-432	48	12	ivan	ivan	PROPN
dpc-432	48	13	ds	ds	PROPN
dpc-432	48	14	,	,	PUNCT
dpc-432	48	15	talpur	talpur	VERB
dpc-432	48	16	r	r	NOUN
dpc-432	48	17	,	,	PUNCT
dpc-432	48	18	duvic	duvic	ADJ
dpc-432	48	19	m.	m.	NOUN
dpc-432	48	20	clinical	clinical	ADJ
dpc-432	48	21	presentation	presentation	NOUN
dpc-432	48	22	,	,	PUNCT
dpc-432	48	23	immunopathology	immunopathology	NOUN
dpc-432	48	24	,	,	PUNCT
dpc-432	48	25	and	and	CCONJ
dpc-432	48	26	treatment	treatment	NOUN
dpc-432	48	27	of	of	ADP
dpc-432	48	28	juvenileonset	juvenileonset	NOUN
dpc-432	48	29	mycosis	mycosis	NOUN
dpc-432	48	30	fungoides	fungoide	VERB
dpc-432	48	31	:	:	PUNCT
dpc-432	48	32	a	a	DET
dpc-432	48	33	case	case	NOUN
dpc-432	48	34	series	series	NOUN
dpc-432	48	35	of	of	ADP
dpc-432	48	36	 	 	SPACE
dpc-432	48	37	34	34	NUM
dpc-432	48	38	 	 	SPACE
dpc-432	48	39	patients	patient	NOUN
dpc-432	48	40	.	.	PUNCT
dpc-432	49	1	j	j	PROPN
dpc-432	49	2	am	be	AUX
dpc-432	49	3	acad	acad	ADJ
dpc-432	49	4	dermatol	dermatol	NOUN
dpc-432	49	5	.	.	PUNCT
dpc-432	50	1	2014;71(6):1117	2014;71(6):1117	NUM
dpc-432	50	2	-	-	SYM
dpc-432	50	3	1126	1126	NUM
dpc-432	50	4	.	.	PUNCT
dpc-432	51	1	3	3	X
dpc-432	51	2	.	.	X
dpc-432	51	3	ai	ai	VERB
dpc-432	51	4	wz	wz	PROPN
dpc-432	51	5	,	,	PUNCT
dpc-432	51	6	keegan	keegan	PROPN
dpc-432	51	7	th	th	PROPN
dpc-432	51	8	,	,	PUNCT
dpc-432	51	9	press	press	NOUN
dpc-432	51	10	dj	dj	NOUN
dpc-432	51	11	,	,	PUNCT
dpc-432	51	12	et	et	PROPN
dpc-432	51	13	 	 	SPACE
dpc-432	51	14	al	al	PROPN
dpc-432	51	15	.	.	PUNCT
dpc-432	52	1	outcomes	outcome	NOUN
dpc-432	52	2	after	after	ADP
dpc-432	52	3	diagnosis	diagnosis	NOUN
dpc-432	52	4	of	of	ADP
dpc-432	52	5	mycosis	mycosis	NOUN
dpc-432	52	6	fungoides	fungoide	NOUN
dpc-432	52	7	and	and	CCONJ
dpc-432	52	8	sézary	sézary	ADJ
dpc-432	52	9	syndrome	syndrome	NOUN
dpc-432	52	10	before	before	ADP
dpc-432	52	11	 	 	SPACE
dpc-432	52	12	30	30	NUM
dpc-432	52	13	 	 	SPACE
dpc-432	52	14	years	year	NOUN
dpc-432	52	15	of	of	ADP
dpc-432	52	16	age	age	NOUN
dpc-432	52	17	:	:	PUNCT
dpc-432	52	18	a	a	DET
dpc-432	52	19	population	population	NOUN
dpc-432	52	20	-	-	PUNCT
dpc-432	52	21	based	base	VERB
dpc-432	52	22	study	study	NOUN
dpc-432	52	23	.	.	PUNCT
dpc-432	53	1	jama	jama	PROPN
dpc-432	53	2	dermatol	dermatol	NOUN
dpc-432	53	3	.	.	PUNCT
dpc-432	54	1	2014;150(7):709	2014;150(7):709	NUM
dpc-432	54	2	-	-	PUNCT
dpc-432	54	3	715	715	NUM
dpc-432	54	4	.	.	PUNCT
dpc-432	55	1	4	4	NUM
dpc-432	55	2	.	.	X
dpc-432	55	3	nanda	nanda	ADV
dpc-432	55	4	a	a	ADV
dpc-432	55	5	,	,	PUNCT
dpc-432	55	6	al	al	PROPN
dpc-432	55	7	-	-	PUNCT
dpc-432	55	8	ajmi	ajmi	PROPN
dpc-432	55	9	h.	h.	PROPN
dpc-432	55	10	mycosis	mycosis	NOUN
dpc-432	55	11	fungoides	fungoide	NOUN
dpc-432	55	12	in	in	ADP
dpc-432	55	13	children	child	NOUN
dpc-432	55	14	and	and	CCONJ
dpc-432	55	15	adolescents	adolescent	NOUN
dpc-432	55	16	.	.	PUNCT
dpc-432	56	1	expert	expert	NOUN
dpc-432	56	2	rev	rev	PROPN
dpc-432	56	3	dermatol	dermatol	NOUN
dpc-432	56	4	.	.	PUNCT
dpc-432	57	1	2013;8(3):309	2013;8(3):309	NOUN
dpc-432	57	2	-	-	PUNCT
dpc-432	57	3	320	320	NUM
dpc-432	57	4	.	.	PUNCT
dpc-432	58	1	5	5	NUM
dpc-432	58	2	.	.	X
dpc-432	58	3	girardi	girardi	PROPN
dpc-432	58	4	m	m	PROPN
dpc-432	58	5	,	,	PUNCT
dpc-432	58	6	heald	heald	PROPN
dpc-432	58	7	pw	pw	PROPN
dpc-432	58	8	,	,	PUNCT
dpc-432	58	9	wilson	wilson	PROPN
dpc-432	58	10	ld	ld	PROPN
dpc-432	58	11	.	.	PUNCT
dpc-432	59	1	the	the	DET
dpc-432	59	2	pathogenesis	pathogenesis	NOUN
dpc-432	59	3	of	of	ADP
dpc-432	59	4	mycosis	mycosis	NOUN
dpc-432	59	5	fungoides	fungoide	NOUN
dpc-432	59	6	.	.	PUNCT
dpc-432	60	1	n	n	PRON
dpc-432	60	2	engl	engl	PROPN
dpc-432	60	3	j	j	PROPN
dpc-432	60	4	med	med	PROPN
dpc-432	60	5	.	.	PUNCT
dpc-432	61	1	2004;350(19):1978	2004;350(19):1978	NUM
dpc-432	61	2	-	-	SYM
dpc-432	61	3	1988	1988	NUM
dpc-432	61	4	.	.	PUNCT
dpc-432	62	1	6	6	NUM
dpc-432	62	2	.	.	PUNCT
dpc-432	62	3	jawed	jawed	ADJ
dpc-432	62	4	si	si	X
dpc-432	62	5	,	,	PUNCT
dpc-432	62	6	myskowski	myskowski	PROPN
dpc-432	62	7	pl	pl	PROPN
dpc-432	62	8	,	,	PUNCT
dpc-432	62	9	horwitz	horwitz	PROPN
dpc-432	62	10	s	s	PROPN
dpc-432	62	11	,	,	PUNCT
dpc-432	62	12	moskowitz	moskowitz	PROPN
dpc-432	62	13	a	a	PROPN
dpc-432	62	14	,	,	PUNCT
dpc-432	62	15	querfeld	querfeld	ADJ
dpc-432	62	16	c.	c.	PROPN
dpc-432	62	17	primary	primary	PROPN
dpc-432	62	18	cutaneous	cutaneous	ADJ
dpc-432	62	19	t	t	PROPN
dpc-432	62	20	-	-	PUNCT
dpc-432	62	21	cell	cell	NOUN
dpc-432	62	22	lymphoma	lymphoma	NOUN
dpc-432	62	23	(	(	PUNCT
dpc-432	62	24	mycosis	mycosis	NOUN
dpc-432	62	25	fungoides	fungoide	NOUN
dpc-432	62	26	and	and	CCONJ
dpc-432	62	27	sézary	sézary	ADJ
dpc-432	62	28	syndrome	syndrome	NOUN
dpc-432	62	29	):	):	PUNCT
dpc-432	62	30	part	part	NOUN
dpc-432	62	31	i.	i.	NOUN
dpc-432	62	32	diagnosis	diagnosis	PROPN
dpc-432	62	33	:	:	PUNCT
dpc-432	62	34	clinical	clinical	ADJ
dpc-432	62	35	and	and	CCONJ
dpc-432	62	36	histopathologic	histopathologic	ADJ
dpc-432	62	37	features	feature	NOUN
dpc-432	62	38	and	and	CCONJ
dpc-432	62	39	new	new	ADJ
dpc-432	62	40	molecular	molecular	ADJ
dpc-432	62	41	and	and	CCONJ
dpc-432	62	42	biologic	biologic	NOUN
dpc-432	62	43	markers	marker	NOUN
dpc-432	62	44	.	.	PUNCT
dpc-432	63	1	j	j	PROPN
dpc-432	63	2	am	be	AUX
dpc-432	63	3	acad	acad	ADJ
dpc-432	63	4	dermatol	dermatol	NOUN
dpc-432	63	5	.	.	PUNCT
dpc-432	64	1	2014;70(2):205	2014;70(2):205	NUM
dpc-432	64	2	-	-	SYM
dpc-432	64	3	216	216	NUM
dpc-432	64	4	.	.	PUNCT
dpc-432	65	1	7	7	X
dpc-432	65	2	.	.	X
dpc-432	65	3	stadler	stadl	ADJ
dpc-432	65	4	r	r	NOUN
dpc-432	65	5	,	,	PUNCT
dpc-432	65	6	assaf	assaf	PROPN
dpc-432	65	7	c	c	PROPN
dpc-432	65	8	,	,	PUNCT
dpc-432	65	9	klemke	klemke	PROPN
dpc-432	65	10	cd	cd	PROPN
dpc-432	65	11	,	,	PUNCT
dpc-432	66	1	et	et	PROPN
dpc-432	66	2	 	 	SPACE
dpc-432	66	3	al	al	PROPN
dpc-432	66	4	.	.	PROPN
dpc-432	66	5	brief	brief	PROPN
dpc-432	66	6	s2k	s2k	PROPN
dpc-432	66	7	guidelines	guideline	NOUN
dpc-432	66	8	—	—	PUNCT
dpc-432	66	9	cutaneous	cutaneous	ADJ
dpc-432	66	10	lymphomas	lymphoma	NOUN
dpc-432	66	11	.	.	PUNCT
dpc-432	67	1	j	j	PROPN
dpc-432	67	2	dtsch	dtsch	PROPN
dpc-432	67	3	dermatol	dermatol	NOUN
dpc-432	67	4	ges	ges	PROPN
dpc-432	67	5	.	.	PROPN
dpc-432	67	6	2013;11	2013;11	NUM
dpc-432	67	7	 	 	SPACE
dpc-432	67	8	suppl	suppl	ADJ
dpc-432	67	9	 	 	SPACE
dpc-432	67	10	3:1930	3:1930	NUM
dpc-432	67	11	.	.	PROPN
dpc-432	67	12	8	8	NUM
dpc-432	67	13	.	.	PUNCT
dpc-432	68	1	wain	wain	PROPN
dpc-432	68	2	em	em	PRON
dpc-432	68	3	,	,	PUNCT
dpc-432	68	4	orchard	orchard	PROPN
dpc-432	68	5	ge	ge	PROPN
dpc-432	68	6	,	,	PUNCT
dpc-432	68	7	whittaker	whittaker	PROPN
dpc-432	68	8	sj	sj	PROPN
dpc-432	68	9	,	,	PUNCT
dpc-432	68	10	spittle	spittle	NOUN
dpc-432	68	11	mf	mf	NOUN
dpc-432	68	12	,	,	PUNCT
dpc-432	68	13	russell	russell	PROPN
dpc-432	68	14	-	-	PUNCT
dpc-432	68	15	jones	jones	PROPN
dpc-432	68	16	r	r	PROPN
dpc-432	68	17	..	..	PUNCT
dpc-432	68	18	outcome	outcome	NOUN
dpc-432	68	19	in	in	ADP
dpc-432	68	20	 	 	SPACE
dpc-432	68	21	34	34	NUM
dpc-432	68	22	 	 	SPACE
dpc-432	68	23	patients	patient	NOUN
dpc-432	68	24	with	with	ADP
dpc-432	68	25	juvenile	juvenile	ADJ
dpc-432	68	26	-	-	PUNCT
dpc-432	68	27	onset	onset	VERB
dpc-432	68	28	mycosis	mycosis	NOUN
dpc-432	68	29	fungoides	fungoide	VERB
dpc-432	68	30	:	:	PUNCT
dpc-432	68	31	a	a	DET
dpc-432	68	32	clinical	clinical	ADJ
dpc-432	68	33	,	,	PUNCT
dpc-432	68	34	immunophenotypic	immunophenotypic	ADJ
dpc-432	68	35	,	,	PUNCT
dpc-432	68	36	and	and	CCONJ
dpc-432	68	37	molecular	molecular	ADJ
dpc-432	68	38	study	study	NOUN
dpc-432	68	39	.	.	PUNCT
dpc-432	69	1	cancer	cancer	NOUN
dpc-432	69	2	.	.	PUNCT
dpc-432	70	1	2003;98(10):2282	2003;98(10):2282	NUM
dpc-432	70	2	-	-	SYM
dpc-432	70	3	2290	2290	NUM
dpc-432	70	4	.	.	PUNCT
dpc-432	71	1	9	9	NUM
dpc-432	71	2	.	.	X
dpc-432	71	3	ceppi	ceppi	PROPN
dpc-432	71	4	f	f	PROPN
dpc-432	71	5	,	,	PUNCT
dpc-432	71	6	pope	pope	NOUN
dpc-432	71	7	e	e	NOUN
dpc-432	71	8	,	,	PUNCT
dpc-432	71	9	ngan	ngan	PROPN
dpc-432	71	10	b	b	PROPN
dpc-432	71	11	,	,	PUNCT
dpc-432	71	12	et	et	PROPN
dpc-432	71	13	  	  	SPACE
dpc-432	71	14	al	al	PROPN
dpc-432	71	15	.	.	PROPN
dpc-432	71	16	primary	primary	ADJ
dpc-432	71	17	cutaneous	cutaneous	ADJ
dpc-432	71	18	lymphomas	lymphoma	NOUN
dpc-432	71	19	in	in	ADP
dpc-432	71	20	children	child	NOUN
dpc-432	71	21	and	and	CCONJ
dpc-432	71	22	adolescents	adolescent	NOUN
dpc-432	71	23	.	.	PUNCT
dpc-432	72	1	pediatr	pediatr	ADJ
dpc-432	72	2	blood	blood	NOUN
dpc-432	72	3	cancer	cancer	NOUN
dpc-432	72	4	.	.	PUNCT
dpc-432	73	1	2016;63(11):1886	2016;63(11):1886	NUM
dpc-432	73	2	-	-	SYM
dpc-432	73	3	1894	1894	NUM
dpc-432	73	4	.	.	PUNCT
dpc-432	74	1	10	10	NUM
dpc-432	74	2	.	.	X
dpc-432	74	3	laws	law	NOUN
dpc-432	74	4	pm	pm	VERB
dpc-432	74	5	,	,	PUNCT
dpc-432	74	6	shear	shear	PROPN
dpc-432	74	7	nh	nh	PROPN
dpc-432	74	8	,	,	PUNCT
dpc-432	74	9	pope	pope	PROPN
dpc-432	74	10	e.	e.	PROPN
dpc-432	74	11	childhood	childhood	PROPN
dpc-432	74	12	mycosis	mycosis	NOUN
dpc-432	74	13	fungoides	fungoide	VERB
dpc-432	74	14	:	:	PUNCT
dpc-432	74	15	experience	experience	NOUN
dpc-432	74	16	of	of	ADP
dpc-432	74	17	 	 	SPACE
dpc-432	74	18	28	28	NUM
dpc-432	74	19	 	 	SPACE
dpc-432	74	20	patients	patient	NOUN
dpc-432	74	21	and	and	CCONJ
dpc-432	74	22	response	response	NOUN
dpc-432	74	23	to	to	ADP
dpc-432	74	24	phototherapy	phototherapy	NOUN
dpc-432	74	25	.	.	PUNCT
dpc-432	75	1	pediatr	pediatr	ADJ
dpc-432	75	2	dermatol	dermatol	NOUN
dpc-432	75	3	.	.	PUNCT
dpc-432	76	1	2014;31(4):459	2014;31(4):459	NUM
dpc-432	76	2	-	-	PUNCT
dpc-432	76	3	464	464	NUM
dpc-432	76	4	.	.	PUNCT
dpc-432	77	1	gies	gy	NOUN
dpc-432	77	2	possibly	possibly	ADV
dpc-432	77	3	existing	exist	VERB
dpc-432	77	4	simultaneously	simultaneously	ADV
dpc-432	77	5	[	[	X
dpc-432	77	6	6	6	NUM
dpc-432	77	7	]	]	PUNCT
dpc-432	77	8	.	.	PUNCT
dpc-432	78	1	in	in	ADP
dpc-432	78	2	contrast	contrast	NOUN
dpc-432	78	3	to	to	ADP
dpc-432	78	4	most	most	ADJ
dpc-432	78	5	adult	adult	NOUN
dpc-432	78	6	cases	case	NOUN
dpc-432	78	7	of	of	ADP
dpc-432	78	8	mf	mf	NOUN
dpc-432	78	9	that	that	PRON
dpc-432	78	10	show	show	VERB
dpc-432	78	11	a	a	DET
dpc-432	78	12	predominance	predominance	NOUN
dpc-432	78	13	of	of	ADP
dpc-432	78	14	cd4	cd4	ADJ
dpc-432	78	15	-	-	ADJ
dpc-432	78	16	positive	positive	ADJ
dpc-432	78	17	pathologic	pathologic	ADJ
dpc-432	78	18	t	t	NOUN
dpc-432	78	19	-	-	PUNCT
dpc-432	78	20	cells	cell	NOUN
dpc-432	78	21	,	,	PUNCT
dpc-432	78	22	many	many	ADJ
dpc-432	78	23	pediatric	pediatric	ADJ
dpc-432	78	24	cases	case	NOUN
dpc-432	78	25	(	(	PUNCT
dpc-432	78	26	approximately	approximately	ADV
dpc-432	78	27	 	 	SPACE
dpc-432	78	28	50	50	NUM
dpc-432	78	29	%	%	NOUN
dpc-432	78	30	)	)	PUNCT
dpc-432	78	31	are	be	AUX
dpc-432	78	32	characterized	characterize	VERB
dpc-432	78	33	by	by	ADP
dpc-432	78	34	cd8	cd8	PROPN
dpc-432	78	35	-	-	ADJ
dpc-432	78	36	positive	positive	ADJ
dpc-432	78	37	epidermotropic	epidermotropic	NOUN
dpc-432	78	38	infiltrates	infiltrate	VERB
dpc-432	78	39	[	[	X
dpc-432	78	40	2	2	NUM
dpc-432	78	41	]	]	PUNCT
dpc-432	78	42	.	.	PUNCT
dpc-432	79	1	while	while	SCONJ
dpc-432	79	2	a	a	DET
dpc-432	79	3	number	number	NOUN
dpc-432	79	4	of	of	ADP
dpc-432	79	5	relevant	relevant	ADJ
dpc-432	79	6	molecular	molecular	ADJ
dpc-432	79	7	mechanisms	mechanism	NOUN
dpc-432	79	8	for	for	ADP
dpc-432	79	9	the	the	DET
dpc-432	79	10	manifestation	manifestation	NOUN
dpc-432	79	11	of	of	ADP
dpc-432	79	12	mf	mf	NOUN
dpc-432	79	13	were	be	AUX
dpc-432	79	14	reported	report	VERB
dpc-432	79	15	[	[	X
dpc-432	79	16	5	5	X
dpc-432	79	17	]	]	PUNCT
dpc-432	79	18	the	the	DET
dpc-432	79	19	exact	exact	ADJ
dpc-432	79	20	pathogenesis	pathogenesis	NOUN
dpc-432	79	21	of	of	ADP
dpc-432	79	22	mf	mf	PROPN
dpc-432	79	23	remains	remain	VERB
dpc-432	79	24	 	 	SPACE
dpc-432	79	25	unknown	unknown	ADJ
dpc-432	79	26	.	.	PUNCT
dpc-432	80	1	many	many	ADJ
dpc-432	80	2	of	of	ADP
dpc-432	80	3	the	the	DET
dpc-432	80	4	affected	affected	ADJ
dpc-432	80	5	children	child	NOUN
dpc-432	80	6	are	be	AUX
dpc-432	80	7	diagnosed	diagnose	VERB
dpc-432	80	8	at	at	ADP
dpc-432	80	9	early	early	ADJ
dpc-432	80	10	stages	stage	NOUN
dpc-432	80	11	of	of	ADP
dpc-432	80	12	the	the	DET
dpc-432	80	13	disease	disease	NOUN
dpc-432	80	14	(	(	PUNCT
dpc-432	80	15	stage	stage	NOUN
dpc-432	80	16	ia	ia	PROPN
dpc-432	80	17	:	:	PUNCT
dpc-432	80	18	50	50	NUM
dpc-432	80	19	%	%	NOUN
dpc-432	80	20	,	,	PUNCT
dpc-432	80	21	stage	stage	NOUN
dpc-432	80	22	ib	ib	X
dpc-432	80	23	:	:	PUNCT
dpc-432	80	24	47	47	NUM
dpc-432	80	25	%	%	NOUN
dpc-432	80	26	)	)	PUNCT
dpc-432	81	1	[	[	X
dpc-432	81	2	7,8	7,8	NUM
dpc-432	81	3	]	]	PUNCT
dpc-432	81	4	;	;	PUNCT
dpc-432	81	5	however	however	ADV
dpc-432	81	6	,	,	PUNCT
dpc-432	81	7	a	a	DET
dpc-432	81	8	mean	mean	ADJ
dpc-432	81	9	time	time	NOUN
dpc-432	81	10	interval	interval	NOUN
dpc-432	81	11	from	from	ADP
dpc-432	81	12	first	first	ADJ
dpc-432	81	13	symptoms	symptom	NOUN
dpc-432	81	14	until	until	SCONJ
dpc-432	81	15	a	a	DET
dpc-432	81	16	final	final	ADJ
dpc-432	81	17	diagnosis	diagnosis	NOUN
dpc-432	81	18	of	of	ADP
dpc-432	81	19	five	five	NUM
dpc-432	81	20	years	year	NOUN
dpc-432	81	21	was	be	AUX
dpc-432	81	22	reported	report	VERB
dpc-432	81	23	[	[	X
dpc-432	81	24	8	8	NUM
dpc-432	81	25	]	]	PUNCT
dpc-432	81	26	.	.	PUNCT
dpc-432	82	1	the	the	DET
dpc-432	82	2	prognosis	prognosis	NOUN
dpc-432	82	3	of	of	ADP
dpc-432	82	4	mf	mf	NOUN
dpc-432	82	5	in	in	ADP
dpc-432	82	6	children	child	NOUN
dpc-432	82	7	and	and	CCONJ
dpc-432	82	8	adolescents	adolescent	NOUN
dpc-432	82	9	is	be	AUX
dpc-432	82	10	more	more	ADV
dpc-432	82	11	favorable	favorable	ADJ
dpc-432	82	12	than	than	ADP
dpc-432	82	13	in	in	ADP
dpc-432	82	14	adults	adult	NOUN
dpc-432	82	15	,	,	PUNCT
dpc-432	82	16	with	with	ADP
dpc-432	82	17	 	 	SPACE
dpc-432	82	18	5	5	NUM
dpc-432	82	19	-	-	PUNCT
dpc-432	82	20	year	year	NOUN
dpc-432	82	21	and	and	CCONJ
dpc-432	82	22	 	 	SPACE
dpc-432	82	23	10	10	NUM
dpc-432	82	24	-	-	PUNCT
dpc-432	82	25	year	year	NOUN
dpc-432	82	26	survival	survival	NOUN
dpc-432	82	27	rates	rate	NOUN
dpc-432	82	28	of	of	ADP
dpc-432	82	29	 	 	SPACE
dpc-432	82	30	95	95	NUM
dpc-432	82	31	%	%	NOUN
dpc-432	82	32	and	and	CCONJ
dpc-432	82	33	 	 	SPACE
dpc-432	82	34	93	93	NUM
dpc-432	82	35	%	%	NOUN
dpc-432	82	36	,	,	PUNCT
dpc-432	82	37	respectively	respectively	ADV
dpc-432	82	38	[	[	X
dpc-432	82	39	3,8	3,8	NUM
dpc-432	82	40	]	]	PUNCT
dpc-432	82	41	.	.	PUNCT
dpc-432	83	1	skin	skin	NOUN
dpc-432	83	2	lesions	lesion	NOUN
dpc-432	83	3	of	of	ADP
dpc-432	83	4	the	the	DET
dpc-432	83	5	patient	patient	NOUN
dpc-432	83	6	presented	present	VERB
dpc-432	83	7	as	as	ADP
dpc-432	83	8	erythematous	erythematous	ADJ
dpc-432	83	9	macules	macule	NOUN
dpc-432	83	10	and	and	CCONJ
dpc-432	83	11	plaques	plaque	NOUN
dpc-432	83	12	.	.	PUNCT
dpc-432	84	1	in	in	ADP
dpc-432	84	2	contrast	contrast	NOUN
dpc-432	84	3	,	,	PUNCT
dpc-432	84	4	other	other	ADJ
dpc-432	84	5	authors	author	NOUN
dpc-432	84	6	described	describe	VERB
dpc-432	84	7	a	a	DET
dpc-432	84	8	high	high	ADJ
dpc-432	84	9	frequency	frequency	NOUN
dpc-432	84	10	of	of	ADP
dpc-432	84	11	hypopigmented	hypopigmente	VERB
dpc-432	84	12	mf	mf	NOUN
dpc-432	84	13	lesions	lesion	NOUN
dpc-432	84	14	in	in	ADP
dpc-432	84	15	children	child	NOUN
dpc-432	84	16	often	often	ADV
dpc-432	84	17	associated	associate	VERB
dpc-432	84	18	with	with	ADP
dpc-432	84	19	a	a	DET
dpc-432	84	20	predominance	predominance	NOUN
dpc-432	84	21	of	of	ADP
dpc-432	84	22	cd8	cd8	PROPN
dpc-432	84	23	-	-	ADJ
dpc-432	84	24	positive	positive	ADJ
dpc-432	84	25	atypical	atypical	ADJ
dpc-432	84	26	t	t	NOUN
dpc-432	84	27	-	-	PUNCT
dpc-432	84	28	cells	cell	NOUN
dpc-432	84	29	[	[	X
dpc-432	84	30	8	8	NUM
dpc-432	84	31	]	]	PUNCT
dpc-432	84	32	and	and	CCONJ
dpc-432	84	33	a	a	DET
dpc-432	84	34	non	non	ADJ
dpc-432	84	35	-	-	ADJ
dpc-432	84	36	caucasian	caucasian	ADJ
dpc-432	84	37	skin	skin	NOUN
dpc-432	84	38	phenotype	phenotype	NOUN
dpc-432	84	39	[	[	X
dpc-432	84	40	4	4	NUM
dpc-432	84	41	]	]	PUNCT
dpc-432	84	42	.	.	PUNCT
dpc-432	85	1	the	the	DET
dpc-432	85	2	literature	literature	NOUN
dpc-432	85	3	is	be	AUX
dpc-432	85	4	somewhat	somewhat	ADV
dpc-432	85	5	discordant	discordant	ADJ
dpc-432	85	6	in	in	ADP
dpc-432	85	7	terms	term	NOUN
dpc-432	85	8	of	of	ADP
dpc-432	85	9	tcr	tcr	PROPN
dpc-432	85	10	clonality	clonality	NOUN
dpc-432	85	11	when	when	SCONJ
dpc-432	85	12	assessed	assess	VERB
dpc-432	85	13	in	in	ADP
dpc-432	85	14	skin	skin	NOUN
dpc-432	85	15	biopsies	biopsy	NOUN
dpc-432	85	16	.	.	PUNCT
dpc-432	86	1	while	while	SCONJ
dpc-432	86	2	wain	wain	PROPN
dpc-432	86	3	et	et	PROPN
dpc-432	86	4	 	 	SPACE
dpc-432	86	5	al	al	PROPN
dpc-432	86	6	[	[	X
dpc-432	86	7	8	8	NUM
dpc-432	86	8	]	]	PUNCT
dpc-432	86	9	described	describe	VERB
dpc-432	86	10	monoclonality	monoclonality	NOUN
dpc-432	86	11	of	of	ADP
dpc-432	86	12	tcr	tcr	PROPN
dpc-432	86	13	genes	gene	NOUN
dpc-432	86	14	in	in	ADP
dpc-432	86	15	 	 	SPACE
dpc-432	86	16	26	26	NUM
dpc-432	86	17	 	 	SPACE
dpc-432	86	18	of	of	ADP
dpc-432	86	19	 	 	SPACE
dpc-432	86	20	34	34	NUM
dpc-432	86	21	 	 	SPACE
dpc-432	86	22	cases	case	NOUN
dpc-432	86	23	(	(	PUNCT
dpc-432	86	24	76.5	76.5	NUM
dpc-432	86	25	%	%	NOUN
dpc-432	86	26	)	)	PUNCT
dpc-432	86	27	,	,	PUNCT
dpc-432	86	28	ceppi	ceppi	PROPN
dpc-432	86	29	et	et	PROPN
dpc-432	86	30	 	 	SPACE
dpc-432	86	31	al	al	PROPN
dpc-432	87	1	[	[	X
dpc-432	87	2	9	9	NUM
dpc-432	87	3	]	]	PUNCT
dpc-432	87	4	reported	report	VERB
dpc-432	87	5	of	of	ADP
dpc-432	87	6	only	only	ADV
dpc-432	87	7	 	 	SPACE
dpc-432	87	8	3	3	NUM
dpc-432	87	9	 	 	SPACE
dpc-432	87	10	out	out	ADP
dpc-432	87	11	of	of	ADP
dpc-432	87	12	 	 	SPACE
dpc-432	87	13	14	14	NUM
dpc-432	87	14	 	 	SPACE
dpc-432	87	15	cases	case	NOUN
dpc-432	87	16	(	(	PUNCT
dpc-432	87	17	21.4	21.4	NUM
dpc-432	87	18	%	%	NOUN
dpc-432	87	19	)	)	PUNCT
dpc-432	87	20	.	.	PUNCT
dpc-432	88	1	there	there	PRON
dpc-432	88	2	are	be	VERB
dpc-432	88	3	no	no	DET
dpc-432	88	4	specific	specific	ADJ
dpc-432	88	5	guidelines	guideline	NOUN
dpc-432	88	6	for	for	ADP
dpc-432	88	7	the	the	DET
dpc-432	88	8	therapy	therapy	NOUN
dpc-432	88	9	of	of	ADP
dpc-432	88	10	juvenile	juvenile	ADJ
dpc-432	88	11	mf	mf	NOUN
dpc-432	88	12	.	.	PUNCT
dpc-432	88	13	recommendations	recommendation	NOUN
dpc-432	88	14	for	for	ADP
dpc-432	88	15	first	first	ADJ
dpc-432	88	16	-	-	PUNCT
dpc-432	88	17	line	line	NOUN
dpc-432	88	18	treatment	treatment	NOUN
dpc-432	88	19	of	of	ADP
dpc-432	88	20	mf	mf	PROPN
dpc-432	88	21	stages	stage	NOUN
dpc-432	88	22	ia	ia	PROPN
dpc-432	88	23	,	,	PUNCT
dpc-432	88	24	ib	ib	INTJ
dpc-432	88	25	,	,	PUNCT
dpc-432	88	26	and	and	CCONJ
dpc-432	88	27	iia	iia	NOUN
dpc-432	88	28	are	be	AUX
dpc-432	88	29	either	either	CCONJ
dpc-432	88	30	emollients	emollient	NOUN
dpc-432	88	31	plus	plus	CCONJ
dpc-432	88	32	observation	observation	NOUN
dpc-432	88	33	only	only	ADV
dpc-432	88	34	or	or	CCONJ
dpc-432	88	35	,	,	PUNCT
dpc-432	88	36	as	as	SCONJ
dpc-432	88	37	used	use	VERB
dpc-432	88	38	in	in	ADP
dpc-432	88	39	our	our	PRON
dpc-432	88	40	case	case	NOUN
dpc-432	88	41	,	,	PUNCT
dpc-432	88	42	topical	topical	ADJ
dpc-432	88	43	corticosteroids	corticosteroid	NOUN
dpc-432	88	44	.	.	PUNCT
dpc-432	89	1	in	in	ADP
dpc-432	89	2	refractory	refractory	NOUN
dpc-432	89	3	cases	case	NOUN
dpc-432	89	4	,	,	PUNCT
dpc-432	89	5	topical	topical	ADJ
dpc-432	89	6	corticosteroids	corticosteroid	NOUN
dpc-432	89	7	may	may	AUX
dpc-432	89	8	be	be	AUX
dpc-432	89	9	combined	combine	VERB
dpc-432	89	10	with	with	ADP
dpc-432	89	11	phototherapy	phototherapy	NOUN
dpc-432	89	12	(	(	PUNCT
dpc-432	89	13	broadband	broadband	NOUN
dpc-432	89	14	/	/	SYM
dpc-432	89	15	narrowband	narrowband	PROPN
dpc-432	89	16	ultraviolet	ultraviolet	PROPN
dpc-432	89	17	b	b	PROPN
dpc-432	90	1	[	[	X
dpc-432	90	2	uvb	uvb	ADJ
dpc-432	90	3	]	]	X
dpc-432	90	4	,	,	PUNCT
dpc-432	90	5	psoralen	psoralen	ADJ
dpc-432	90	6	and	and	CCONJ
dpc-432	90	7	ultraviolet	ultraviolet	ADJ
dpc-432	90	8	a	a	DET
dpc-432	90	9	[	[	X
dpc-432	90	10	puva])[1	puva])[1	NOUN
dpc-432	90	11	]	]	X
dpc-432	90	12	.	.	PUNCT
dpc-432	91	1	most	most	ADJ
dpc-432	91	2	authors	author	NOUN
dpc-432	91	3	prefer	prefer	VERB
dpc-432	91	4	narrowband	narrowband	NOUN
dpc-432	91	5	uvb	uvb	ADJ
dpc-432	91	6	to	to	PART
dpc-432	91	7	broadband	broadband	VERB
dpc-432	91	8	uvb	uvb	ADJ
dpc-432	91	9	or	or	CCONJ
dpc-432	91	10	puva	puva	PROPN
dpc-432	91	11	because	because	SCONJ
dpc-432	91	12	of	of	ADP
dpc-432	91	13	its	its	PRON
dpc-432	91	14	decreased	decrease	VERB
dpc-432	91	15	carcinogenic	carcinogenic	ADJ
dpc-432	91	16	potential	potential	NOUN
dpc-432	91	17	and	and	CCONJ
dpc-432	91	18	less	less	ADJ
dpc-432	91	19	side	side	ADJ
dpc-432	91	20	effects	effect	NOUN
dpc-432	91	21	[	[	X
dpc-432	91	22	1,10	1,10	NUM
dpc-432	91	23	]	]	PUNCT
dpc-432	91	24	.	.	PUNCT
dpc-432	92	1	as	as	ADP
dpc-432	92	2	for	for	ADP
dpc-432	92	3	any	any	DET
dpc-432	92	4	phototherapy	phototherapy	NOUN
dpc-432	92	5	in	in	ADP
dpc-432	92	6	children	child	NOUN
dpc-432	92	7	,	,	PUNCT
dpc-432	92	8	it	it	PRON
dpc-432	92	9	should	should	AUX
dpc-432	92	10	be	be	AUX
dpc-432	92	11	kept	keep	VERB
dpc-432	92	12	in	in	ADP
dpc-432	92	13	mind	mind	NOUN
dpc-432	92	14	that	that	SCONJ
dpc-432	92	15	mf	mf	VERB
dpc-432	92	16	is	be	AUX
dpc-432	92	17	a	a	DET
dpc-432	92	18	chronic	chronic	ADJ
dpc-432	92	19	disease	disease	NOUN
dpc-432	92	20	with	with	ADP
dpc-432	92	21	slow	slow	ADJ
dpc-432	92	22	progression	progression	NOUN
dpc-432	92	23	.	.	PUNCT
dpc-432	93	1	repeated	repeat	VERB
dpc-432	93	2	phototherapies	phototherapy	NOUN
dpc-432	93	3	along	along	ADP
dpc-432	93	4	the	the	DET
dpc-432	93	5	course	course	NOUN
dpc-432	93	6	of	of	ADP
dpc-432	93	7	the	the	DET
dpc-432	93	8	disease	disease	NOUN
dpc-432	93	9	may	may	AUX
dpc-432	93	10	eventu	eventu	VERB